An Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome Patients(RegiSONIC)
Stopped The study was terminated early by the Sponsor due to the high rate of discontinuation of subjects unrelated to patient safety.
Conditions
Sponsor
Genentech, Inc.